Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity? - Prattichizzo, F.; Giuliani, A.; De Nigris, V.; Pujadas, G.; Ceka, A.; La Sala, L.; Genovese, S.; Testa, R.; Procopio, A. D.; Olivieri, F.; Ceriello, A. (Diabetes, obesity & metabolism, 2016)
Keywords: Aging; Aging - metabolism; antidiabetic drug; Antidiabetics; cardiovascular disease; Cell interactions; Cellular Senescence; Clinical trials; Diabetes; diabetes complications; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - metabolism; Diabetic Angiopathies - metabolism; Diabetic Angiopathies - physiopathology; Endothelium, Vascular - metabolism; Endothelium, Vascular - physiopathology; Epigenesis, Genetic; Epigenetics; Exosomes; extracellular vesicles; Extracellular Vesicles - metabolism; extracellular vesicles, exosomes; Gene expression; glycaemic control; Humans; Hyperglycemia - metabolism; Hypoglycemic Agents - therapeutic use; Inflammation; metabolic memory; metformin; MicroRNAs; MicroRNAs - metabolism; miRNA; Review; Senescence; type 2 diabetes; microRNAs; cardiovascular disease; type 2 diabetes; extracellular vesicles, exosomes; antidiabetic drug; metformin; glycaemic control; metabolic memory; diabetes complications